An email about the latest emerging trends and new ideas.
This newsletter's hiatus explained. Plus news, commentary, and fancy tomatoes.
*but in a slightly different format
Plus, neovaginas, biomaterials, and a personal stake in genetic testing.
Plus, circumcision is falling in popularity, and we need an embryo regulator.
Plus, CRISPR blindness trial is successful and mushrooms on the runway
Plus, a bunch of biotech companies got a lot of money!
Plus, medical abortions, gene therapy hearings, and new egg freezing rules.
See all

Sex, Drugs, and Biotech